Theseus Pharmaceuticals Statistics
Total Valuation
OMEX has a market cap or net worth of $44.18 million. The enterprise value is $65.49 million.
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025, before market open.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OMEX has 31.34 million shares outstanding. The number of shares has increased by 59.52% in one year.
| Current Share Class | 31.34M |
| Shares Outstanding | 31.34M |
| Shares Change (YoY) | +59.52% |
| Shares Change (QoQ) | +86.32% |
| Owned by Insiders (%) | 7.22% |
| Owned by Institutions (%) | 6.07% |
| Float | 24.45M |
Valuation Ratios
The trailing PE ratio is 6.20.
| PE Ratio | 6.20 |
| Forward PE | n/a |
| PS Ratio | 46.58 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 117.57 |
| P/OCF Ratio | 124.03 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 4.55 |
| EV / Sales | 93.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 174.25 |
Financial Position
The company has a current ratio of 0.13
| Current Ratio | 0.13 |
| Quick Ratio | 0.11 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 63.23 |
| Interest Coverage | -1.62 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -32.62% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 129.89% |
| Revenue Per Employee | $63,692 |
| Profits Per Employee | $1.31M |
| Employee Count | 11 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.88% in the last 52 weeks. The beta is -0.77, so OMEX's price volatility has been lower than the market average.
| Beta (5Y) | -0.77 |
| 52-Week Price Change | -64.88% |
| 50-Day Moving Average | 1.22 |
| 200-Day Moving Average | 0.73 |
| Relative Strength Index (RSI) | 50.30 |
| Average Volume (20 Days) | 2,908,682 |
Short Selling Information
The latest short interest is 3.56 million, so 11.37% of the outstanding shares have been sold short.
| Short Interest | 3.56M |
| Short Previous Month | 3.24M |
| Short % of Shares Out | 11.37% |
| Short % of Float | 14.57% |
| Short Ratio (days to cover) | 1.24 |
Income Statement
In the last 12 months, OMEX had revenue of $700,613 and earned $14.40 million in profits. Earnings per share was $0.23.
| Revenue | 700,613 |
| Gross Profit | -2.09M |
| Operating Income | -9.51M |
| Pretax Income | -3.55M |
| Net Income | 14.40M |
| EBITDA | -9.43M |
| EBIT | -9.51M |
| Earnings Per Share (EPS) | $0.23 |
Full Income StatementBalance Sheet
The company has $2.46 million in cash and $23.76 million in debt, giving a net cash position of -$21.30 million or -$0.68 per share.
| Cash & Cash Equivalents | 2.46M |
| Total Debt | 23.76M |
| Net Cash | -21.30M |
| Net Cash Per Share | -$0.68 |
| Equity (Book Value) | -79.44M |
| Book Value Per Share | -0.48 |
| Working Capital | -20.05M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $356,225 and capital expenditures $19,593, giving a free cash flow of $375,818.
| Operating Cash Flow | 356,225 |
| Capital Expenditures | 19,593 |
| Free Cash Flow | 375,818 |
| FCF Per Share | $0.01 |
Full Cash Flow StatementMargins
Gross margin is -298.38%, with operating and profit margins of -1,357.87% and 2,055.55%.
| Gross Margin | -298.38% |
| Operating Margin | -1,357.87% |
| Pretax Margin | 700.89% |
| Profit Margin | 2,055.55% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 53.64% |
Dividends & Yields
OMEX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -59.52% |
| Shareholder Yield | -59.52% |
| Earnings Yield | 32.59% |
| FCF Yield | 0.85% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 22, 2016. It was a reverse split with a ratio of 1:12.
| Last Split Date | Feb 22, 2016 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
OMEX has an Altman Z-Score of -27.77 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -27.77 |
| Piotroski F-Score | 4 |
